Novavax (NVAX) EPS (Diluted) (QoQ) (2020 - 2026)
Novavax (NVAX) EPS (Diluted) (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Novavax | 788.01 Mn | -2.33 Mn | 108.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -157.41% |
| Dec 31, 2025 | 108.12% |
| Sep 30, 2025 | -307.41% |
| Jun 30, 2025 | -79.42% |
| Mar 31, 2025 | 648.41% |
| Dec 31, 2024 | 29.75% |
| Sep 30, 2024 | -177.41% |
| Jun 30, 2024 | 192.84% |
| Mar 31, 2024 | 40.43% |
| Dec 31, 2023 | -40.01% |
| Sep 30, 2023 | -326.83% |
| Jun 30, 2023 | 116.34% |
| Mar 31, 2023 | -46.34% |
| Dec 31, 2022 | -8.21% |
| Sep 30, 2022 | 67.03% |
| Jun 30, 2022 | -359.21% |
| Mar 31, 2022 | 122.16% |
| Dec 31, 2021 | -163.69% |
| Sep 30, 2021 | 9.25% |
| Jun 30, 2021 | -55.88% |